drugset / Trial / NCT00547885

Randomized Controlled Double Blind Trial of Short vs Long Acting Dihydrocodeine in Chronic Non-malignant Pain

NCT00547885

Phase 4 Completed 60 enrolled Norwegian University of Science and Technology
RandomizedParallel-groupTriple-blindTreatment

Summary

We wish to compare the effect of long acting vs short acting opioids in chronic non-malignant pain. The study opioid is Dihydrocodeine Continus and Dihydrocodeine 30 mg tablets. We measure pain relief, health related quality of life, sleep, breakthrough pain and depression with validated questionnaires to compare the two treatment arms. Hypothesis: The pain relief will be better and more stable with long acting opioids. Quality of sleep, breakthrough pain and quality of life will also be improved with long acting dihydrocodeine.

Timeline

Start
2007-10
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dihydrocodeine Small molecule 30 mg
Comparator Dihydrocodeine Small molecule 60 mg

Indications

No indication recorded.